Entrance of novel therapies will drive Niemann-Pick type C disease market growth
The Niemann-Pick Type C disease market is expected to grow from $128.35m last year to $188.35m in 2031 across the 3MM.
Source: pharmaceutical-technology.com
Chain Refrigerated News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chain Refrigerated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chain Refrigerated Today - Breaking & Trending Today
California's low-cost insulin plans receive $100m manufacturing boost
Governor Newsom unveils plans to work with a CMO to produce low-cost insulin, as most big pharma insulin is currently produced in-house.
Source: pharmaceutical-technology.com
FDA committee recommends EUA for Novavax's Covid-19 vaccine
The FDA VRBPAC voted 21 to 0 recommending the grant of EUA for Novavax’s Covid-19 vaccine, NVX-CoV2373, for people aged 18 years and above.
Source: pharmaceutical-technology.com
Biogen, Alectos collaborate to develop Parkinson's disease treatment
Biogen has entered into a license and collaboration agreement with Alectos Therapeutics to develop and commercialise AL01811 to treat PD.
Source: pharmaceutical-technology.com
Advanz Pharma to acquire Intercept's subsidiaries and operations
Advanz Pharma agreed to acquire subsidiaries and operations of Intercept Pharmaceuticals in Canada, Europe and all markets outside the US.
Source: pharmaceutical-technology.com